Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Roivant Sciences Ltd.
Updated Jul 16, 2026
Fitzgerald Meghan has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $2.27M.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 10.0K | $34.90 | $349K |
| 2026-07-02 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 10.0K | $8.80 | $88K |
| 2026-05-27 | THC | TENET HEALTHCARE CORP | D — Derivative transaction | 493 | $173.78 | $86K |
| 2026-05-27 | THC | TENET HEALTHCARE CORP | M — Option exercise | 1.3K | — | |
| 2026-03-31 | ROIV | Roivant Sciences Ltd. | S — Open-market sale | 70.0K | $27.45 | $1.92M |
| 2026-03-31 | ROIV | Roivant Sciences Ltd. | M — Option exercise | 70.0K | $8.80 | $616K |
| 2025-09-10 | ROIV | Roivant Sciences Ltd. | J — Other acquisition / disposition | 937 | $13.77 | $13K |
| 2025-09-10 | ROIV | Roivant Sciences Ltd. | A — Grant or award | 14.5K | $0.00 |
Fitzgerald Meghan is a corporate insider — currently tracked as Director of Roivant Sciences Ltd. (ROIV). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($2.27M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Fitzgerald Meghan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.